Lehigh University logo
Lehigh University logo

Henry L. Dorkin

Dr. Henry L. Dorkin ’70 holds several roles at Boston Children's Hospital, including Director of the Pulmonary Clinical Research Program, Co-Director of the Cystic Fibrosis Center and Co-Director of the Cystic Fibrosis Therapeutic Development Center. In 2017, he will be serving as President of the Massachusetts Medical Society (MMS).

Dorkin graduated cum laude from Lehigh in 1970. During his time at Lehigh, he was a member of the National Engineering Honorary Society of Tau Beta Pi. Dorkin attended the Johns Hopkins University School of Medicine. Dorkin completed his residency and became a Parker B. Francis Research Fellow in Pulmonary Disease and Cystic Fibrosis at Harvard Medical School and Children's Hospital.

Following his time at Children’s Hospital, Dorkin was asked to form the Pediatric Pulmonary Unit at the Tufts University Medical School and the New England Medical Center's Floating Hospital for Children. He also served as an ICU Attending and Director of the Cystic Fibrosis Center at the Floating Hospital. While there, Dorkin performed the first inhalational gene therapy trial in Cystic Fibrosis patients in the world.

Dorkin also served as professor of pediatrics until 2002 when he joined the Massachusetts General Hospital and Harvard Medical School as Director of the Joey O'Donnell Cystic Fibrosis Center and Co-Director of the CF Therapeutic Development Research Program. In that role, Dorkin helped develop a number of new therapies for Cystic Fibrosis. Dorkin has also served as an associate professor of pediatrics at Harvard Medical School.

Dorkin has been a member of the Medical Society since 1982 and has served as an important benefactor in various ways, both as vice president and as a member of the board of trustees. Previously, Dorkin served as president of the Suffolk District Medical Society. His service on the MMS has extended to multiple committees, including its finance and strategic planning operations.

In 1981 he established the Division of Respiratory Diseases at the Tufts University School of Medicine and was its division chief until 2002 when he moved to the faculty of the Harvard Medical School. Additionally, Dorkin has conducted research and authored studies on a variety of topics about cystic fibrosis, pediatric and respiratory medicines. Today, he continues as a manuscript reviewer for a number of medical journals.